Why the study?
Does the MediGuide 3D catheter tracking system reduce fluoroscopy exposure without compromising safety and efficacy in patients undergoing catheter ablation of typical atrial flutter?
Does the MediGuide 3D catheter tracking system reduce fluoroscopy exposure without compromising safety and efficacy in patients undergoing catheter ablation of typical atrial flutter?
The MediGuide 3D catheter tracking system may offer a safe and effective alternative to conventional fluoroscopy for atrial flutter ablation, with the benefit of reduced radiation exposure.
May support reduced fluoroscopy in SVT ablation; leaves open need for randomized confirmation of safety and efficacy.
The MediGuide™ system is a novel technology for non-fluoroscopic 3D catheter tracking during cardiovascular electrophysiological procedures. The system allows for precise catheter visualization on pre-recorded conventional fluoroscopy images, with significant reduction of fluoroscopy exposure. This might translate into improved safety for both patients and operators, without affecting the procedural efficacy. Preliminary data suggest that the MediGuide technology is at least as safe and effective as conventional systems for mapping and catheter ablation of a variety of supraventricular arrhythmias, with a significantly reduced fluoroscopy exposure. In this review, the authors summarize data from the available literature data on catheter ablation of typical atrial flutter using the novel MediGuide technology.
No takes yet. Share an insight, caveat, or question.
Muser et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: